Fesoterodine
Back to searchMolecule Structure
Scientific Name
Fesoterodine
Description of the Drug
Fesoterodine is an antimuscarinic agent used in the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06702
http://www.drugbank.ca/drugs/DB06702
Brand Name(s)
Not Available
Company Owner(s)
Alkem Laboratories Ltd, Aurobindo Pharma Ltd, Dr Reddys Laboratories Ltd, Zydus Pharmaceuticals Usa Inc, Pfizer Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Muscarinic acetylcholine receptor M3 | SINGLE PROTEIN | ANTAGONIST | CHEMBL245 |
Muscarinic acetylcholine receptor M2 | SINGLE PROTEIN | ANTAGONIST | CHEMBL211 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL121127 | ||
PharmGKB | PA165958376 | ||
Human Metabolome Database | HMDB0015648 | ||
DrugBank | DB06702 | ||
PubChem: Thomson Pharma | 14781939 | ||
PubChem | 6918558 | ||
Nikkaji | J2.587.519B | ||
EPA CompTox Dashboard | DTXSID80182853 | ||
DrugCentral | 4191 | ||
Guide to Pharmacology | 7473 | ||
rxnorm | FESOTERODINE | FESOTERODINE FUMARATE | TOVIAZ |
ChEBI | 135920 | ||
ZINC | ZINC000001552908 |